Google News
logo
Diseases - General Knowledge Questions
A)
Neuron
B)
Nephron
C)
Granule
D)
Granulocyte

Correct Answer : Option (B) - Nephron

Nephrons are the cells of kidney which are considered as smallest functional unit because it is microscopic structure which actively participates in functions of kidney like blood filtration and osmoregulation. A healthy adult has 0.8 to 1.5 million nephrons in each kidney.

A)
Vivotif
B)
Typherix
C)
Typhim VI
D)
Typbar Typhoid Conjugate

Correct Answer : Option (D) - Typbar Typhoid Conjugate

Biological ELimited (BE), a Hyderabad-based vaccines and pharmaceutical company, has announced that its Typhoid Conjugate Vaccine (TCV) has been pre-qualified by the World Health Organisation (WHO).

A)
Poor hygiene & Overuse of steroids
B)
Poor hygiene, Moisture and heat & Contaminated food
C)
Poor hygiene, Moisture and heat, Contaminated food & Overuse of steroids
D)
Moisture and heat, Contaminated food & Overuse of steroids

Correct Answer : Option (C) - Poor hygiene, Moisture and heat, Contaminated food & Overuse of steroids

A)
Facial Swelling, Nasal Congestion & Headache
B)
Facial Swelling & Nasal Congestion
C)
Nasal Congestion
D)
Facial Swelling

Correct Answer : Option (A) - Facial Swelling, Nasal Congestion & Headache

Black Fungus or Mucormycosis symptoms include facial swelling, nasal congestion, and headache. If the lungs are infected then the symptoms include fever, cough, and shortness of breath.

A)
December 2020
B)
January 2021
C)
February 2021
D)
March 2021

Correct Answer : Option (D) - March 2021

On 1 March, 2021, the second phase of vaccination started in India that allows all Indians above the age of 60 and Indians between the age of 45 and 59 with comorbidities to be vaccinated.

A)
Favipiravir is an antiviral COVID-19 drug.
B)
Glenmark Pharmaceuticals under the brand name FabiFlu has launched an antiviral drug Favipiravir.
C)
It is India's first COVID-19 drug launched, priced at Rs 103 per tablet.
D)
All of the above

Correct Answer : Option (D) - All of the above

Favipiravir is an antiviral COVID-19 drug. Glenmark Pharmaceuticals under the brand name FabiFlu has launched an antiviral drug Favipiravir. It is India's first COVID-19 drug launched, priced at Rs 103 per tablet.

A)
D-Cell
B)
T-Cell
C)
P-cell
D)
Endothelial Cells

Correct Answer : Option (B) - T-Cell

T cells are known as immune warriors help us fight some viruses, but their importance for battling SARS-CoV-2, the virus that causes COVID-19, has been unclear. Research is going on and maybe it can be fruitful.

A)
BNT162
B)
PICOVACC
C)
Both (a) and (b)
D)
None of the above

Correct Answer : Option (A) - BNT162

BNT162 is jointly developed by the German company BioNTech and US pharma giant Pfizer. It is a group of four potential vaccines based on the messenger RNA or mRNA, concept. On the other hand, PICOVACC is an inactivated vaccine developed by the private biopharma company Sinovac. These vaccines are in clinical trial phases.

A)
MERS
B)
SARS
C)
Both (a) and (b)
D)
Neither (a) nor (b)

Correct Answer : Option (C) - Both (a) and (b)

Coronavirus may cause illness from the common cold to more other serious diseases like Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV).

A)
Fever
B)
Cough
C)
Shortness of breath
D)
All of the above

Correct Answer : Option (D) - All of the above

Most common symptoms :
* fever
* dry cough
* tiredness
 
Less common symptoms:
* aches and pains
* sore throat
* diarrhoea
* conjunctivitis
* headache
* loss of taste or smell
* a rash on skin, or discolouration of fingers or toes
 
Serious symptoms:
* difficulty breathing or shortness of breath
* chest pain or pressure
* loss of speech or movement
 
Seek immediate medical attention if you have serious symptoms. Always call before visiting your doctor or health facility.
 
People with mild symptoms who are otherwise healthy should manage their symptoms at home.
 
On average it takes 5–6 days from when someone is infected with the virus for symptoms to show, however it can take up to 14 days.